APOE and cerebral amyloid angiopathy in community-dwelling older persons

Neurobiology of Aging

Volumn 36, Issue 11, 2015, Pages 2946-2953

  Yu, Lei ^a,b   Boyle, Patricia A ^a,b   Nag, Sukriti ^a,b   Leurgans, Sue ^a,b   Buchman, Aron S ^a,b   Wilson, Robert S ^a,b   Arvanitakis, Zoe ^a,b   Farfel, Jose M ^b,c   De Jager, Philip L ^d,e,f   Bennett, David A ^a,b   Schneider, Julie A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

Alzheimer's disease; APOE; Capillaries; Cerebral amyloid angiopathy

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

AGED; AGING; ALZHEIMER DISEASE; APOE GENE; ARTICLE; AUTOPSY; CODON; DISEASE SEVERITY; DNA POLYMORPHISM; EXON; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VASCULAR AMYLOIDOSIS; VERY ELDERLY; ALLELE; GENETIC ASSOCIATION STUDY; GENETICS; HETEROZYGOTE; PATHOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HETEROZYGOTE; HUMANS; LOGISTIC MODELS; MALE; SEVERITY OF ILLNESS INDEX;

EID: 84947020619     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.08.008     Document Type: Article

References (49)

1. Alonzo N.C., Hyman B.T., Rebeck G.W., Greenberg S.M. Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels. J. Neuropathol. Exp. Neurol. 1998, 57:353-359.
2. Arold S., Sullivan P., Bilousova T., Teng E., Miller C.A., Poon W.W., Vinters H.V., Cornwell L.B., Saing T., Cole G.M., Gylys K.H. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex. Acta Neuropathol. 2012, 123:39-52.
3. Arvanitakis Z., Leurgans S.E., Barnes L.L., Bennett D.A., Schneider J.A. Microinfarct pathology, dementia, and cognitive systems. Stroke 2011, 42:722-727.
4. Arvanitakis Z., Leurgans S.E., Wang Z., Wilson R.S., Bennett D.A., Schneider J.A. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann. Neurol. 2011, 69:320-327.
5. Auriel E., Greenberg S.M. The pathophysiology and clinical presentation of cerebral amyloid angiopathy. Curr. Atheroscler. Rep. 2012, 14:343-350.
6. Bennett D.A., Schneider J.A., Arvanitakis Z., Kelly J.F., Aggarwal N.T., Shah R.C., Wilson R.S. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006, 66:1837-1844.
7. Bennett D.A., Schneider J.A., Arvanitakis Z., Wilson R.S. Overview and findings from the religious orders study. Curr. Alzheimer Res. 2012, 9:628.
8. Bennett D.A., Schneider J.A., Buchman A.S., Barnes L.L., Boyle P.A., Wilson R.S. Overview and findings from the Rush Memory and Aging Project. Curr. Alzheimer Res. 2012, 9:646.
9. Bennett D.A., Schneider J.A., Tang Y., Arnold S.E., Wilson R.S. The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol. 2006, 5:406-412.
10. Biffi A., Anderson C.D., Jagiella J.M., Schmidt H., Kissela B., Hansen B.M., Jimenez-Conde J., Pires C.R., Ayres A.M., Schwab K., Cortellini L., Pera J., Urbanik A., Romero J.M., Rost N.S., Goldstein J.N., Viswanathan A., Pichler A., Enzinger C., Rabionet R., Norrving B., Tirschwell D.L., Selim M., Brown D.L., Silliman S.L., Worrall B.B., Meschia J.F., Kidwell C.S., Broderick J.P., Greenberg S.M., Roquer J., Lindgren A., Slowik A., Schmidt R., Woo D., Rosand J. APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol. 2011, 10:702-709.
11. Biffi A., Sonni A., Anderson C.D., Kissela B., Jagiella J.M., Schmidt H., Jimenez-Conde J., Hansen B.M., Fernandez-Cadenas I., Cortellini L., Ayres A., Schwab K., Juchniewicz K., Urbanik A., Rost N.S., Viswanathan A., Seifert-Held T., Stoegerer E.M., Tomas M., Rabionet R., Estivill X., Brown D.L., Silliman S.L., Selim M., Worrall B.B., Meschia J.F., Montaner J., Lindgren A., Roquer J., Schmidt R., Greenberg S.M., Slowik A., Broderick J.P., Woo D., Rosand J. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann. Neurol. 2010, 68:934-943.
12. Boyle P.A., Buchman A.S., Wilson R.S., Kelly J.F., Bennett D.A. The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons. Neuroepidemiology 2010, 34:43-49.
13. Brouwers H.B., Biffi A., McNamara K.A., Ayres A.M., Valant V., Schwab K., Romero J.M., Viswanathan A., Greenberg S.M., Rosand J., Goldstein J.N. Apolipoprotein E genotype is associated with CT angiography spot sign in lobar intracerebral hemorrhage. Stroke 2012, 43:2120-2125.
14. Burgermeister P., Calhoun M.E., Winkler D.T., Jucker M. Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models. Ann. N. Y. Acad. Sci. 2000, 903:307-316.
15. Cadavid D., Mena H., Koeller K., Frommelt R.A. Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J. Neuropathol. Exp. Neurol. 2000, 59:768-773.
16. Calhoun M.E., Burgermeister P., Phinney A.L., Stalder M., Tolnay M., Wiederhold K.H., Abramowski D., Sturchler-Pierrat C., Sommer B., Staufenbiel M., Jucker M. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:14088-14093.
17. Carare R.O., Bernardes-Silva M., Newman T.A., Page A.M., Nicoll J.A., Perry V.H., Weller R.O. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol. Appl. Neurobiol. 2008, 34:131-144.
18. Castellano J.M., Kim J., Stewart F.R., Jiang H., DeMattos R.B., Patterson B.W., Fagan A.M., Morris J.C., Mawuenyega K.G., Cruchaga C., Goate A.M., Bales K.R., Paul S.M., Bateman R.J., Holtzman D.M. Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci. Transl. Med. 2011, 3:89ra57.
19. Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A.M., Armstrong D.L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 2003, 9:907-913.
20. Deramecourt V., Slade J.Y., Oakley A.E., Perry R.H., Ince P.G., Maurage C.A., Kalaria R.N. Staging and natural history of cerebrovascular pathology in dementia. Neurology 2012, 78:1043-1050.
21. Devan W.J., Falcone G.J., Anderson C.D., Jagiella J.M., Schmidt H., Hansen B.M., Jimenez-Conde J., Giralt-Steinhauer E., Cuadrado-Godia E., Soriano C., Ayres A.M., Schwab K., Kassis S.B., Valant V., Pera J., Urbanik A., Viswanathan A., Rost N.S., Goldstein J.N., Freudenberger P., Stogerer E.M., Norrving B., Tirschwell D.L., Selim M., Brown D.L., Silliman S.L., Worrall B.B., Meschia J.F., Kidwell C.S., Montaner J., Fernandez-Cadenas I., Delgado P., Greenberg S.M., Roquer J., Lindgren A., Slowik A., Schmidt R., Woo D., Rosand J., Biffi A. Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage. Stroke 2013, 44:1578-1583.
22. Greenberg S.M., Rebeck G.W., Vonsattel J.P., Gomez-Isla T., Hyman B.T. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann. Neurol. 1995, 38:254-259.
23. Greenberg S.M., Vonsattel J.P. Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke 1997, 28:1418-1422.
24. Greenberg S.M., Vonsattel J.P., Segal A.Z., Chiu R.I., Clatworthy A.E., Liao A., Hyman B.T., Rebeck G.W. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998, 50:961-965.
25. Herzig M.C., Van Nostrand W.E., Jucker M. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol. 2006, 16:40-54.
26. Herzig M.C., Winkler D.T., Burgermeister P., Pfeifer M., Kohler E., Schmidt S.D., Danner S., Abramowski D., Sturchler-Pierrat C., Burki K., van Duinen S.G., Maat-Schieman M.L., Staufenbiel M., Mathews P.M., Jucker M. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat. Neurosci. 2004, 7:954-960.
27. Holtzman D.M., Bales K.R., Tenkova T., Fagan A.M., Parsadanian M., Sartorius L.J., Mackey B., Olney J., McKeel D., Wozniak D., Paul S.M. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:2892-2897.
28. Love S., Chalmers K., Ince P., Esiri M., Attems J., Jellinger K., Yamada M., McCarron M., Minett T., Matthews F., Greenberg S., Mann D., Kehoe P.G. Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am. J. Neurodegener. Dis. 2014, 3:19-32.
29. Love S., Miners S., Palmer J., Chalmers K., Kehoe P. Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy. Front. Biosci. (Landmark Ed.) 2009, 14:4778-4792.
30. McCarron M.O., Nicoll J.A. Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage. Ann. N. Y. Acad. Sci. 2000, 903:176-179.
31. McCarron M.O., Nicoll J.A., Stewart J., Ironside J.W., Mann D.M., Love S., Graham D.I., Dewar D. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J. Neuropathol. Exp. Neurol. 1999, 58:711-718.
32. Nelson P.T., Pious N.M., Jicha G.A., Wilcock D.M., Fardo D.W., Estus S., Rebeck G.W. APOE-epsilon2 and APOE-epsilon4 correlate with increased amyloid accumulation in cerebral vasculature. J. Neuropathol. Exp. Neurol. 2013, 72:708-715.
33. Obici L., Demarchi A., de Rosa G., Bellotti V., Marciano S., Donadei S., Arbustini E., Palladini G., Diegoli M., Genovese E., Ferrari G., Coverlizza S., Merlini G. A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. Ann. Neurol. 2005, 58:639-644.
34. Olichney J.M., Hansen L.A., Galasko D., Saitoh T., Hofstetter C.R., Katzman R., Thal L.J. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996, 47:190-196.
35. Premkumar D.R., Cohen D.L., Hedera P., Friedland R.P., Kalaria R.N. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol. 1996, 148:2083-2095.
36. Rannikmae K., Kalaria R.N., Greenberg S.M., Chui H.C., Schmitt F.A., Samarasekera N., Al-Shahi Salman R., Sudlow C.L. APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis. J. Neurol. Neurosurg. Psychiatry 2014, 85:300-305.
37. Roses A.D., Saunders A.M. APOE is a major susceptibility gene for Alzheimer's disease. Curr. Opin. Biotechnol. 1994, 5:663-667.
38. Samarasekera N., Smith C., Al-Shahi Salman R. The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry 2012, 83:275-281.
39. Schneider J.A., Arvanitakis Z., Yu L., Boyle P.A., Leurgans S.E., Bennett D.A. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain 2012, 135(Pt 10):3005-3014.
40. Schneider J.A., Bienias J.L., Wilson R.S., Berry-Kravis E., Evans D.A., Bennett D.A. The apolipoprotein E epsilon4 allele increases the odds of chronic cerebral infarction [corrected] detected at autopsy in older persons. Stroke 2005, 36:954-959.
41. Serrano-Pozo A., Qian J., Monsell S.E., Betensky R.A., Hyman B.T. APOE epsilon2 is associated with milder clinical and pathological Alzheimer's disease. Ann. Neurol. 2015, 77:917-929.
42. Thal D.R., Ghebremedhin E., Rub U., Yamaguchi H., Del Tredici K., Braak H. Two types of sporadic cerebral amyloid angiopathy. J. Neuropathol. Exp. Neurol. 2002, 61:282-293.
43. Tsuang D., Leverenz J.B., Lopez O.L., Hamilton R.L., Bennett D.A., Schneider J.A., Buchman A.S., Larson E.B., Crane P.K., Kaye J.A., Kramer P., Woltjer R., Trojanowski J.Q., Weintraub D., Chen-Plotkin A.S., Irwin D.J., Rick J., Schellenberg G.D., Watson G.S., Kukull W., Nelson P.T., Jicha G.A., Neltner J.H., Galasko D., Masliah E., Quinn J.F., Chung K.A., Yearout D., Mata I.F., Wan J.Y., Edwards K.L., Montine T.J., Zabetian C.P. APOE epsilon4 increases risk for dementia in pure synucleinopathies. JAMA Neurol. 2013, 70:223-228.
44. Tzourio C., Arima H., Harrap S., Anderson C., Godin O., Woodward M., Neal B., Bousser M.G., Chalmers J., Cambien F., MacMahon S. APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology 2008, 70:1322-1328.
45. Valant V., Keenan B.T., Anderson C.D., Shulman J.M., Devan W.J., Ayres A.M., Schwab K., Goldstein J.N., Viswanathan A., Greenberg S.M., Bennett D.A., De Jager P.L., Rosand J., Biffi A. TOMM40 in cerebral amyloid angiopathy related intracerebral hemorrhage: comparative genetic analysis with Alzheimer's disease. Transl. Stroke Res. 2012, 3(Suppl 1):102-112.
46. Van Dorpe J., Smeijers L., Dewachter I., Nuyens D., Spittaels K., Van Den Haute C., Mercken M., Moechars D., Laenen I., Kuiperi C., Bruynseels K., Tesseur I., Loos R., Vanderstichele H., Checler F., Sciot R., Van Leuven F. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons. Am. J. Pathol. 2000, 157:1283-1298.
47. Weller R.O., Massey A., Newman T.A., Hutchings M., Kuo Y.M., Roher A.E. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am. J. Pathol. 1998, 153:725-733.
48. Weller R.O., Subash M., Preston S.D., Mazanti I., Carare R.O. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol. 2008, 18:253-266.
49. Yu L., Boyle P.A., Leurgans S., Schneider J.A., Bennett D.A. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol. Aging 2014, 35:819-826.